Phase IIb Study of F-1311 in Patients with Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 12 Jul 2017
At a glance
- Drugs Technetium tc 99m trofolastat (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Adverse reactions; Diagnostic use
- Sponsors FUJIFILM RI Pharma
- 11 Jul 2017 Status changed from recruiting to completed.
- 09 Nov 2016 Planned End Date changed from 31 Oct 2016 to 31 Mar 2017.
- 10 Jun 2016 New trial record